. 1961 Nov:3:46-51.

Sensitization to the very high frequency blood factor Vel, with observations on the occurrence of the very rare Vel-negative type among siblings

A S WIENER et al. Bull Brooklyn. 1961 Nov.

. 1961 Nov:3:46-51.

No abstract available

Similar articles

[Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
Vućinović M, Jadrić H, Karelović D, Roje D, Haspl-Hundrić Z, Hrgović Z, Vućinović Z. Vućinović M, et al. Z Geburtshilfe Neonatol. 2004 Oct;208(5):197-202. doi: 10.1055/s-2004-832639. Z Geburtshilfe Neonatol. 2004. PMID: 15508054 German.
Haemolytic disease of the newborn because of rare anti-Vel.
van Gammeren AJ, Overbeeke MA, Idema RN, van Beek RH, Ten Kate-Booij MJ, Ermens AA. van Gammeren AJ, et al. Transfus Med. 2008 Jun;18(3):197-8. doi: 10.1111/j.1365-3148.2008.00863.x. Transfus Med. 2008. PMID: 18598283
[Study of the VEL factor in the Marseilles population apropos of a case of anti-VEL immunization].
Battaglini PF, Ranque J, Bridonneau C, Salmon C, Nicoli RM. Battaglini PF, et al. Bibl Haematol. 1965;23:309-11. Bibl Haematol. 1965. PMID: 5879893 French. No abstract available.
SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression.
Christophersen MK, Jöud M, Ajore R, Vege S, Ljungdahl KW, Westhoff CM, Olsson ML, Storry JR, Nilsson B. Christophersen MK, et al. Sci Rep. 2017 Jan 13;7:40451. doi: 10.1038/srep40451. Sci Rep. 2017. PMID: 28084402 Free PMC article.
PCR-ELISA for high-throughput blood group genotyping.
St-Louis M. St-Louis M. Methods Mol Biol. 2009;496:3-13. doi: 10.1007/978-1-59745-553-4_1. Methods Mol Biol. 2009. PMID: 18839100 Review.

When recombinant proteins can replace rare red cells in immunohematology workups.
Flegel WA, Srivastava K. Flegel WA, et al. Transfusion. 2021 Jul;61(7):2204-2212. doi: 10.1111/trf.16507. Epub 2021 May 31. Transfusion. 2021. PMID: 34060094 Free PMC article. No abstract available.